1. Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, Parhizkar S, Ward MA, Cavallini A, Jackson S, Bose S, Clavaguera F, Tolnay M, Lavenir I, Goedert M, Hutton ML, O'Neill MJ. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol 2014;127:667–683. doi: 10.1007/s00401-014-1254-6.
2. Amaral DG, Scharfman HE, Lavenex P. The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Progr Brain Res 2007; 163: 3-22. doi: 10.1016/S0079-6123(07)63001-5.
3. Andorfer C, Kress Y, de Silva SM, Tucker KL, Barde YA, Duff K, Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003; 86: 582-590. doi: 10.1046/j.1471-4159.2003.01879.x.
4. Andreadis A. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta 2005; 1739:91-103. doi: 10.1016/j.bbadis.2004.08.010.
5. Andrés-Benito P, Carmona M, Jordán Pirla M, Torrejón-Escribano B, del Rio JA, Ferrer I. Dysregulated protein phosphorylation as main contributor of granulovacuolar degeneration at the first stages of NFT pathology. Neuroscience. Under revision
6. Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull 2016;126: 238-292. doi: 10.1016/j.brainresbull.2016.08.018.
7. Audouard E, Houben S, Masaracchia C, Yilmaz Z, Suain V, Authelet M, De Decker R, Buée L, Boom A, Leroy K, Ando K, Brion JP. High-molecular weight paired helical filaments from Alzheimer brain induces seeding of wild-type mouse tau into argyrophilic 4R tau pathology in vivo. Am J Pathol 2016; 186:2709-2722. doi: 10.1016/j.ajpath.2016.06.008.
8. Avila J, Lucas JJ, Perez M, Hernandez F. Role of tau protein in both physiological and pathological conditions. Physiol Rev 2004;84:361-84. doi: 10.1152/physrev.00024.2003.
9. Boluda S, Iba M, Zhang B, Raible KM, Lee VM, Trojanowski JQ. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains. Acta Neuropathol 2015;129:221–237 doi: 10.1007/s00401-014-1373-0.
10. Buckmaster PS, Strowbridge BW, Kunkel DD, Schmiege DL, Schwartzkroin PA. Mossy cell axonal projections to the dentate gyrus molecular layer in the rat hippocampal slice. Hippocampus 1992;2:349–362. doi: 10.1002/hipo.450020403.
11. Bullmann T, de Silva R, Holzer M, Mori H, Arendt T. Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus. Hippocampus 2007; 17: 98-102. doi: 10.1002/hipo.20255
12. Claiborne BJ, Amaral DG, Cowan WM. A light and electron microscopic analysis of the mossy fibers of the rat dentate gyrus. J Comp Neurol 1986;246:435-458. doi: 10.1002/cne.902460403.
13. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 111:909-913. doi: 10.1038/ncb1901.
14. Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, Ghetti B, Goedert M, Tolnay M. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci USA 2013; 110:9535-9540. doi: 10.1073/pnas.1301175110.
15. Clavaguera F, Hench J, Goedert M, Tolnay M. Invited review: prion-like transmission and spreading of tau pathology. Neuropathol Appl Neurobiol 2015;41:47-58. doi: 10.1111/nan.12197.
16. Dammer EB, Lee AK, Duong DM, Gearing M, Lah JJ, Levey AI, Seyfried N. Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics 2015;15:508-519. doi: 10.1002/pmic.201400189
17. Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N, Corjuc DL, Corjuc BT, Dooley PM, Viode A, Oakley DH, Moore BD, Mullin K, Jean-Gilles D, Clark R, Atchison K, Moore R, Chibnik LB, Tanzi RE, Frosch MP, Serrano-Pozo A, Elwood F, Steen JA, Kennedy ME, Hyman BT. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med 2020;26:1256-1263. doi: 10.1038/s41591-020-0938-9.
18. Duncan PI, Stojdl DF, Marius RM, Scheit KH, Bell JC. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence premRNA splicing. Exp Cell Res 1998; 241: 300-308. doi: 10.1006/excr.1998.4083.
19. Ferrer I, Aguiló García M, López González I, Diaz Lucena D, Roig Villalonga A, Carmona M, Llorens F, Garcia-Esparcia P, Martinez-Maldonado A, Frau Mendez M, Torrejón Escribano B, Bech-Serra JJ, Sabido E, de la Torre Gómez C, Del Rio JA. Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes. Brain Pathol 2018; 28: 965-985. doi: 10.1111/bpa.12593. E
20. Ferrer I, Aguiló García M, Carmona M, Andrés-Benito P, Torrejón-Escribano B, Garcia-Esparcia P, del Rio JA. Involvement of oligodendrocytes in tau seeding and spreading in tauopathies Front Aging Neurosci 2019; 11:112. doi: 10.3389/fnagi.2019.00112.
21. Ferrer I, Andrés-Benito P, Sala-Jarque J, Gil V, Del Rio JA. Capacity for seeding and spreading of argyrophilic grain disease in a wild-type murine model; comparisons with primary age-related tauopathy. Front Mol Neurosci 2020a; 13:101. doi: 10.3389/fnmol.2020.00101.
22. Ferrer I, Andrés-Benito P, Zelaya MV, Aguirre MEE, Carmona M, Ausín K, Lachén-Montes M, Fernández-Irigoyen J, Santamaría E, Del Rio JA. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Acta Neuropathol 2020b;139:735-771. doi: 10.1007/s00401-019-02122-9.
23. Ferrer I, Zelaya MV, Aguiló García M, Carmona M, López-González I, Andrés-Benito P López-González I, Andrés-Benito P, Lidón L, Gavín R, Garcia-Esparcia P, Del Rio JA. Relevance of host tau in tau seeding and spreading in tauopathies. Brain Pathol 2020c; 30 :298-318. doi: 10.1111/bpa.12778.
24. Ferrer I. Brain banking. In: Aminoff MJ, Daroff RB, eds. Encyclopedia of the Neurological Sciences, 2nd ed. Vol. 1. Oxford: Academic Press; 2014;467‐473
25. Frotscher M, Seress L, Schwerdtfeger WK, Buhl E. The mossy cells of the fascia dentata: a comparative study of their fine structure and synaptic connections in rodents and primates. J Comp Neurol 1991;312:145–163. doi: 10.1002/cne.903120111.
26. Funk KE, Mrak RE, Kuret J. Granulovacuolar degeneration (GVD) bodies of Alzheimer’s disease (AD) resemble late-stage autophagic organelles. Neuropathol Appl Neurobiol 2011; 37:295-306.
27. Gaarskjaer FB. Organization of the mossy fiber system of the rat studied in extended hippocampi. II. Experimental analysis of fiber distribution with silver impregnation methods. J Comp Neurol 1978;178:73-88. doi: 10.1002/cne.901780105.
28. Gao QS, Memmott J, Lafyatis R, Stamm S, Screaton G, Andreadis A. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J Neurochem 2000; 74:490-500. doi: 10.1046/j.1471-4159.2000.740490.x.
29. Goedert M. Tau proteinopathies and the prion concept. Prog Mol Biol Transl Sci 2020;175: 239-259. doi: 10.1016/bs.pmbts.2020.08.003.
30. Goedert M, Eisenberg DS, Crowther RA. Propagation of tau aggregates and neurodegeneration Annu Rev Neurosci 2017; 40:189-210. doi: 10.1146/annurev-neuro-072116-031153.
31. Goedert M, Spillantini MG. Propagation of tau aggregates. Mol Brain 2017; 10:18. doi: 10.1186/s13041-017-0298-7
32. Goedert M, Spillantini MG. Ordered assembly of tau protein and neurodegeneration. In: Tau Biology, Advances in Experimental Medicine and Biology. Takashima A, Wolozin B, Buee L (eds). Singapore: Springer Nature. 2019: 1-21.
33. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule associated protein tau. Proc Natl Acad Sci USA 1988; 85 : 4051-4055. doi: 10.1073/pnas.85.11.4051
34. Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 2001; 36: 89-101. doi: 10.1002/glia.1098.
35. Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B, Gathagan RJ, Iba M, McBride JD, Trojanowski JQ, Lee VM. Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice. J Exp Med 2016; 213:2635–2654. doi: 10.1084/jem.20160833
36. Hefti MM, Farrell K, Kim S, Bowles KR, Fowkes ME, Raj T, Crary JF. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. PLoS One 2018; 13:e0195771. doi: 10.1371/journal.pone.0195771.
37. Hernandez F, Perez M, Lucas JJ, Mata AM, Bhat R, Avila J. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications 376 Neurosci Bull April 1, 2014, 30(2): 367–377 for Alzheimer's disease. J Biol Chem 2004; 279: 3801-3806. doi: 10.1074/jbc.M311512200
38. Hitt BD, Vaquer-Alicea J, Manon VA, Beaver JD, Kashmer OM, Garcia JN, Diamond MI. Ultrasensitive tau biosensor cells detect no seeding in Alzheimer's disease. CSF Acta Neuropathol Commun 2021;9:99. doi: 10.1186/s40478-021-01185-8.
39. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer’s disease hippocampus. Am J Pathol 2009;174:1241-1251. doi: 10.2353/ajpath.2009.080814.
40. Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J Neurosci 2013; 33: 1024-1037.
41. Iqbal K, Liu F, Gong CX. Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 2016;12:15-27. doi: 10.1038/nrneurol.2015.225.
42. Janke C, Beck M, Stahl T, Holzer M, Brauer K, Bigl V, Arendt T. Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders Brain Res Mol Brain Res 1999;68:119-28. doi: 10.1016/s0169-328x(99)00079-0.
43. Jiang L, Zhao J, Cheng JX, Wolozin B. Tau oligomers and fibrils exhibit differential patterns of seeding and association with RNA binding proteins. Front Neurol 2020;11:579434. doi: 10.3389/fneur.2020.579434.
44. Kampers T, Pangalos M, Geerts H, Wiech H, Mandelkow E. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models of Alzheimer’s disease. FEBS Lett 1999;451:39-44. doi: 10.1016/s0014-5793(99)00522-0.
45. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X, Zhiren Liu, She Chen, Jane Y Wu. RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol Cell Biol 2011; 31: 1812-1821. doi: 10.1128/MCB.01149-10.
46. Köhler C (2016) Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology. Acta Neuropathologica 2016;132: 339-359. doi: 10.1007/s00401-016-1562-0.
47. Kondo S, Yamamoto N, Murakami T, Okumura M, Mayeda A, Imaizumi K. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau premRNA. Genes Cells 2004; 9: 121-130. doi: 10.1111/j.1356-9597.2004.00709.x.
48. Kovacs GG. Invited review: Neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 2015;41:3-23. doi: 10.1111/nan.12208.
49. Kovacs GG. Tauopathies. Handb Clin Neurol. 2017;145:355-368. doi: 10.1016/B978-0-12-802395-2.00025-0.
50. Kvissel AK, Orstavik S, Eikvar S, Brede G, Jahnsen T, Collas P, Göran Akusjärvi, Bjørn Steen Skålhegg. Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing. Exp Cell Res 2007; 313: 2795-2809. doi: 10.1016/j.yexcr.2007.05.014.
51. Lai MC, Lin RI, Tarn WY. Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc Natl Acad Sci USA 2001; 98: 10154-10159. doi: 10.1073/pnas.181354098.
52. Laurberg S, Sorensen KE. Associational and commissural collaterals of neurons in the hippocampal formation (hilus fasciae dentate and subfield CA3). Brain Res 1981;212:287-300. doi: 10.1016/0006-8993(81)90463-7.
53. Lee G, Cowan N, Kirschner M (1988) The primary structure and heterogeneity of tau protein from mouse brain. Science 1988; 239:285-288. doi: 10.1126/science.3122323.
54. Lewis J, Dickson DW. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 2016;131:27-48. doi: 10.1007/s00401-015-1507-z.
55. Li L, Shi R, Gu J, Tung YC, Zhou Y, Zhou D, Wu R, Chu D, Jin N, Deng K, Xu J, Gong CX, Iqbal K, Liu F. Alzheimer's disease brain contains tau fractions with differential prion-like activities. Acta Neuropathol Commun 2021;9:28. doi: 10.1186/s40478-021-01127-4.
56. Liu C, Götz J (2013) Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS ONE 2013; 8:e84849. doi: 10.1371/journal.pone.0084849.
57. Liu M, Sui D, Dexheimer T, Hovde S, Deng X, Wang KW, Lin HL, Chien HT, Kweon HK, Kuo NS, Ayoub CA, Jimenez-Harrison D, Andrews PC, Kwok R, Bochar DA, Kuret J, Fortin J, Tsay YG, Kuo MH. Hyperphosphorylation renders tau prone to aggregate and to cause cell death. Mol Neurobiol 2020;57:4704-4719. doi: 10.1007/s12035-020-02034-w.
58. López-González I, Aso E, Carmona M, Armand-Ugon M, Blanco R, Naudí A, Cabré R, Portero-Otin M, Pamplona R, Ferrer I. Neuroinflammatory gene regulation, mitochondrial function, oxidative stress, and brain lipid modifications with disease progression in tau P301S transgenic mice as a model of frontotemporal lobar degeneration-tau. J Neuropathol Exp Neurol 2015;74: 975-999. doi: 10.1097/NEN.0000000000000241.
59. LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI. Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci USA 1995; 92: 10369-10373. doi: 10.1073/pnas.92.22.10369.
60. McMillan P, Korvatska E, Poorkaj P, Evstafjeva Z, Robinson L, Greenup L, Leverenz J, Schellenberg GD, D'Souza I. Tau isoform regulation is region and cell-specific in mouse brain. J Comp Neurol 2008; 511:788-803. doi: 10.1002/cne.21867.
61. Mermoud JE, Cohen PT, Lamond AI. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 1994; 13: 5679-5688. PMID: 7988565
62. Mudner A, Colin M, Dujardin S, Medina M, Dewachter I, Naini SMA, Mandelkow EM, Mandelkow E, Luc Buée L, Michel Goedert M, Brion JP. What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 2017; 5:99. doi :1186/s40478-017-0488-7
63. Narashima S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV, He Z, Zhang B, Gathagan RJ, Trojanowski JQ, Lee VMY. Pathological tau strains from human brains recapitulate the diversity of tauopathies in non-transgenic mouse brain. J Neurosci 2017;37: 11406-11423. doi: 10.1523/JNEUROSCI.1230-17.2017.
64. Patel NA, Kaneko S, Apostolatos HS, Bae SS, Watson JE, Davidowitz K, David S Chappell, Morris J Birnbaum, Jin Q Cheng, Denise R Cooper. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40. J Biol Chem 2005 ; 280: 14302-14309. doi: 10.1074/jbc.M411485200.
65. Peeraer E, Bottelbergs A, Van Kolen K, Stancu IC, Vasconcelos B, Mahieu M, Duytschaever H, Ver Donck L, Torremans A, Sluydts E, Van Acker N, Kemp JA, Mercken M, Brunden KR, Trojanowski JQ, Dewachter I, Lee VM, Moechars D. Intracerebral injection of preformed synthetic fibrils initiates widesprad tauopathy and neuronal loss in the brains of tau transgenic mice. Neurobiol Dis 2015;73:83-95. doi: 10.1016/j.nbd.2014.08.032.
66. Pitera AP, Asuni AA, O’Connor V, Deinhardt K. Pathogenic tau does not drive activation of the unfolded protein response J Biol Chem 2019; 294: 9679-9688. Doi: 10.1074/jbc.RA119.008263
67. Qian W, Liang H, Shi J, Jin N, Grundke-Iqbal I, Iqbal K, Gong XC, Liu F. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res 2011; 39: 6161-6171. doi: 10.1093/nar/gkr195.
68. Qian W, Liu F. Review· Regulation of alternative splicing of tau exon 10. Neurosci Bull 2014; 30: 367-377. doi: 10.1007/s12264-013-1411-2.
69. Ray P, Kar A, Fushimi K, Havlioglu N, Chen X, Wu JY. PSF suppresses tau exon 10 inclusion by interacting with a stemloop structure downstream of exon 10. J Mol Neurosci 2011; 45: 453-466. doi: 10.1007/s12031-011-9634-z.
70. Reynolds MR, Reyes JF,1 Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer’s disease and other tauopathies. J Neurosci 2006; 26:1036-1045. doi: 10.1523/JNEUROSCI.2143-06.2006.
71. Sathe G, Mangalaparthi KK, Jain A, Darrow J, Troncoso J, Albert M, Troncoso J, Albert M, Moghekar A, Pandey A. Multiplexed phosphoproteomic study of the brain in patients with Alzheimer's disease and age-matched cognitively healthy controls. OMICS 2020;24:2016-2227.doi: 10.1089/omi.2019.0191
72. Sayas CL, Medina M, Cuadros R, Ollá I, García E, Pérez M, Ferrer I, Hernández F, Avila J. Role of tau N-terminal motif in the secretion of human tau by End Binding proteins. PLoS ONE 2019; 14:e0210864. doi: 10.1371/journal.pone.0210864.
73. Shi J, Qian W, Yin X, Iqbal K, Grundke-Iqbal I, Gu X, Ding F, Gong CX, Liu F. Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer's disease. J Biol Chem 2011; 286: 14639-14648. doi: 10.1074/jbc.M110.204453.
74. Sobrido MJ, Miller BL, Havlioglu N, Zhukareva V, Jiang Z, Nasreddine ZS, Lee VMY, Chow TW, Wilhelmsen KC, Cummings JL, Wu JY, Geschwind DH. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch Neurol 2003; 60:698-702. doi: 10.1001/archneur.60.5.698.
75. Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998;21:428-433. doi: 10.1016/S1474-4422(13)70090-5.
76. Stefanoska K, Volkerling A, Bertz J, Poljak A, Ke YD, Ittner LM. An N-terminal motif unique to primate tau enables differential protein-protein interactions. J Biol Chem 2018; 293: 3710-3719. doi: 10.1074/jbc.RA118.001784
77. Stojdl DF, Bell JC. SR protein kinases: the splice of life. Biochem Cell Biol 1999; 77: 293-298. PMID: 10546892
78. Swanson LW, Wyss JM, Cowan WM. An autoradiographic study of the organization of intrahippocampal association pathways in the rat. J Comp Neurol 1978;181:681-716. doi: 10.1002/cne.901810402.
79. Tseng JH, Ajit A, Tabassum Z, Patel N, Tian X, Chen Y, Prevatte AW, Ling K, Rigo F, Meeker RB, Herring LE, Cohen TJ. Tau seeds are subject to aberrant modifications resulting in distinct signatures. Cell Rep 2021;35:109037. doi: 10.1016/j.celrep.2021.109037.
80. Vaquer-Alicea J, Diamond MI, Joachimiak LA. Tau strains shape disease. Acta Neuropathologica (2021) 142:57-71. https://doi.org/10.1007/s00401-021-02301-7
81. Villa González M, Vallés-Saiz L, Hernández IH, Avila J, Hernández F, Pérez-Alvarez MJ. Focal cerebral ischemia induces changes in oligodendrocytic tau isoforms in the damaged area. Glia 2020;68:2471-2485. doi: 10.1002/glia.23865.
82. Wang J, Gao QS, Wang Y, Lafyatis R, Stamm S, Andreadis A. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem 2004; 88:1078-1090. doi: 10.1046/j.1471-4159.2003.02232.x.
83. Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski, Lee VMY. Insoluble tau from human FTDP-17 cases exhibit unique transmission properties in vivo. J Neuropathol Exp Neurol 2020;79: 941-949. doi: 10.1093/jnen/nlaa086.
84. Wiersma VI, van Ziel AM, Vazquez‑Sanchez S, Nölle A, Berenjeno‑Correa E, Bonaterra‑Pastra A, Clavaguera F, Tolnay M, Musters RJP, van Weering JRT, Verhage M, Hoozemans JJM, Scheper W (2019) Granulovacuolar degeneration bodies are neuron‑selective lysosomal structures induced by intracellular tau pathology. Acta Neuropathologica 138:943-970. doi: 10.1007/s00401-019-02046-4.
85. Wu JY, Kar A, Kuo D, Yu B, Havlioglu N. SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identifi ed by an expression cloning strategy. Mol Cell Biol 2006; 26: 6739- 6747. doi: 10.1128/MCB.00739-06.
86. Yin X, Jin N, Gu J, Shi J, Zhou J, Gong CX, Khalid Iqbal, Inge Grundke-Iqbal, Fei Liu. Dual specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)- promoted tau exon 10 inclusion. J Biol Chem 2012; 287: 30497-30506. doi: 10.1074/jbc.M112.355412.
87. Zareba-Paslawska J, Patra K, Kluzer L, Revesz T, Svenningsson P. Tau isoform-driven CBD pathology transmission in oligodendrocytes in humanized tau mice. Front Neurol 2021;11:589471. doi: 10.3389/fneur.2020.589471.